Medical advancements don’t only happen because of scientists and doctors – they rely on a host of other experts as well, including innovations from medical technology companies.

Fujifilm’s award-winning Synapse® Vendor Neutral Archive (VNA) is a prime example. Synapse VNA was initially developed to improve imaging and data interoperability within and between healthcare organizations. However, the solution also has proven to be paramount to the clinical trial process. As a result of its ability to improve imaging study logistics, monitoring, and analytics, the sophisticated software platform was recently named a finalist in the Best Sponsor-facing Technology Initiative category in the 2021 Citeline Awards.

The nod came during an exceptionally competitive year for the award, which aims to recognize the importance of using quality platforms to optimize data gathered during clinical trials.

Fujifilm’s Synapse VNA enables the secure capture, organization, and sharing of patient imaging and data. It accumulates all pertinent patient information in one centralized location so care teams have unrestricted access to the complete patient health picture regardless of where the various pieces of data were acquired.

Fujifilm recently expanded its platform to the realm of clinical trials in which interoperability was a major challenge. The company collaborated with Dr. Colin Miller, chief executive of BrackenData, to help Fujifilm’s Synapse VNA evolve into a product that would best serve biopharma companies and contract research organizations. BrackenData provides clinical trial teams with data science support and continuous, unrestricted access to a proprietary global database.

Working together, Fujifilm and BrackenData were able to develop a global imaging repository aimed at overcoming obstacles caused by multiple research organizations working on a single clinical trial. At that point, data that once took weeks to be shared between researchers could be done instantly. If a biopharma company wants to share data with a business partner, they no longer need to ship hard drives or USBs, build, and test VPNs and go through a credentialing process for each person who needs access. Stakeholders no longer need to have conversations about networks, devices, housing, security, and storage.

Instead, with Fujifilm’s VNA, the company can grant individuals immediate access to data by simply creating a secure login.

The result is a product that can allow its biopharmaceutical customers to advance clinical trial programs, internally monitor study participants and discuss key findings with researchers and consultants worldwide. It’s a solution that gives the world’s best scientific minds access to the information they need to provide medical solutions seamlessly and efficiently for all.

There is a wealth of opportunities available in the Wisconsin biohealth industry and the full Biohealth Innovation Territory (BIT). Learn more about careers at our career center.